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Resident macrophages are distributed throughout the organs and tissues of the body, where they are thought to play a central role in both innate and specific immune responses and in the maintenance of normal homeostatic mechanisms such as hemopoiesis. The precise function of macrophages within specific microenvironments such as the bone marrow or the brain is poorly understood, but it appears that these cells maintain a discrete set of surface receptors which are specific for their particular anatomical/functional location and which appear to be controlled in a spatially and temporally precise manner.
The way in which tissue macrophages interact with other cells and with components of the extracellular matrix is of particular interest. Our laboratory has described a macrophage-restricted receptor that has a lectin-like specificity for ligands containing terminal sialic acid residues (1) . This receptor, known as SER or sialoadhesin, was characterized by means of its functional capacity to bind sheep erythrocytes in the absence of divalent cations. Following the development of a specific monoclonal antibody (mAb), , the receptor was isolated by affinity chromatography and shown to be a glycoprotein of 185 kDa (reduced) or 175 kDa (nonreduced) (3). The isolated protein at nanomolar concentrations was capable of agglutinating sheep and human erythrocytes, and this agglutination could be inhibited with gangliosides such as GT1b and GD1a, suggesting that the receptor reacts preferentially with oligosaccharides containing terminal sialic acid as Neu5Aca2-3Gal(31-3GalNAc.
Immunocytochemical analyses with SER-4 mAb demonstrated high levels of receptor expression within discrete locations, including resident macrophages of the bone marrow, subcapsular sinus macrophages of the lymph nodes, and marginal metallophil cells of the spleen (2) . Immunoelectron microscopy on isolated hemopoietic clusters from adult bone marrow showed that sialoadhesin molecules appeared to concentrate at areas of contact between the central macrophag;is and developing granulocytes (4). This location is suggestive of a functional role for sialoadhesin in the development of granulocytes. While isolated resident or inflammatory elicited peritoneal macrophages express low levels of sialoadhesin, a striking upregulation in expression can be achieved by cultivating the cells in the presence of mouse serum (5) . The inducing activity within the serum has not been fully characterized, but recent work suggests that it is a 60-to 70-kDa protein with a pI of 4.8 (A.S.M. and P.T., unpublished observations).
The possibility that a serum component is responsible for either induction or maintenance of sialoadhesin expression in vivo within very discrete cell populations suggested to us that there may be other factors responsible for regulating expression. In the present study we have examined a number of cytokines for their capacity to either induce sialoadhesin or regulate its expression in the presence of a positive serum induction signal. While none of the cytokines studied were able to induce expression of sialoadhesin, interleukin 4 (IL-4) specifically prevented its induction in the presence of mouse serum. This effect was selective for sialoadhesin, as F4/80, which was also upregulated by serum, was not affected. Reagents and Antibodies. The mAbs SER-4 and 3D6, specific for sialoadhesin, were prepared as described (2, 3) . F4/80 antibody was prepared and purified as previously (6k. The IL-4-neutralizing antibody llBil (7) macrophage activation and F4/80 as another serum-inducible marker (A.S.M. and P.T., unpublished observations). Table  2 shows that exposure to IL4 at 20 ng/ml for 72 hr increased expression of Ia by 50% compared with background levels in Opti-MEM alone. Macrophages cultivated in 2% mouse serum showed a 30% reduction in Ia, and in the presence of both mouse serum and IL4 the increase seen with IL4 alone was suppressed. This suggests that factors in mouse serum alter or prevent IL-4-mediated activation of macrophages. Levels of Mac-2 in macrophage lysates were not affected by exposure to either mouse serum or IL4. F4/80 was upregulated by >90%6 in the presence of mouse serum, but this increase was not affected by IL4.
MATERIALS AND METHODS
IL-4 Prevents Expression of Funcional Slalodhesin. The effect of IL-4 on the capacity of macrophages to form rosettes via sialoadhesin can be seen from Fig. 1 . Control RPMs in the absence of mouse serum (Fig. 1A) showed no sialoadhesin expression after 48 hr in culture, whereas almost 100%o formed rosettes in the presence of 2% mouse serum (Fig. 1B) . mAbs SER4 and 3D6 blocked rosette formation, and neuraminidasetreated erythrocytes were unable to rosette, confirming that the rosetting was entirely due to sialoadhesin. IL4 by itself had no effect on sialoadhesin (Fig. 1C ) but prevented its induction by mouse serum (Fig. 1D) . The IL4-neutralizing antibody llBll had no effect on sialoadhesin induction when tested by itself (Fig. 1E ) or in the presence of mouse serum, but blocked the prevention of induction by IL4 in the presence of mouse serum (Fig. 1F) . Of two rat mAbs against the murine IL4 receptor (8) tested, one (Ml) blocked the inhibitory effects ofIL4 completely, and the second (M2) partially. Fig. 2 shows that cultivation of RPMs in 2% mouse serum resulted in an induction of sialoadhesin total antigen that was prevented by IL-4. This effect was again neutralized by antibody llBll. In contrast, the upregulation of F4/80 by mouse serum was unaffected by IL-4. Interestingly, the combination of IL-4, liBil, and mouse serum appeared to result in a greater expression of F4/80 than mouse serum and IL-4, suggesting that perhaps F4/80 levels are regulated by the presence of immune complexes. This observation has been confirmed by dot blotting (data not shown).
Dose-Response and Kietcs of IL-4 Inhibition f Sodhesin Induction. The effect of IL4 is apparent at 2 ng/ml and fully expressed at 20 ng/ml (Fig. 3A) . Sialoadhesin induction by 2% mouse serum can be detected by enhanced erythrocyte binding after 12 hr in culture (Fig. 3B) (Fig. 4B) . At this level of mouse serum, IL4 at 20 ng/ml will block induction (compare Fig. 3A) ; however, (28, 29) , to enhance tumoricidal (28) and microbicidal activities (30) , and to prime cells for a respiratory burst (31) . In contrast, in human monocytes, IL-4 can inhibit H202 production and anti-leishmanial capacity due to interferon y (32) and can suppress tumor necrosis factor a, IL-1, and prostaglandin E2 production (33) . IL-4 may be suppressive or stimulatory to the macrophages, possibly depending on the degree of differentiation, the local tissue microenvironment, and the influence of other cytokines. The present data indicate that IL-4 may influence the nature ofthe macrophage response to inflammation and the trophic functions of resident stromal macrophages by selectively regulating specific surface receptors involved in interactions with other cells. increased amount of serum may provide a more powerful induction signal, so that any effect of IL-4 is minimized; (ii) soluble, high-affinity IL-4-binding protein, present in mouse serum (10, 11) , can bind the IL-4 and render it inactive.
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The role of the stromal resident macrophages in hemopoiesis is unclear, but it is well known that they are able to form close associations with immature myelomonocytic cells (12) (13) (14) and with erythroblastic precursors (15) (16) (17) (18) (19) . This association can be demonstrated both in vivo, following staining of bone marrow with mAbs such as F4/80, and in long-term in vitro bone marrow cultures (20, 21) . Although these associations are well documented, there is little direct evidence defining the role of macrophages in the developmental regulation of the clustered cells.
Distinct hemagglutinins appear to be important in the attachment ofmyeloid and erythroid precursors to bone marrow macrophages via sialoadhesin and a divalent cation-dependent adhesion receptor (22) . Our present results show that IL4 is highly selective in its downmodulation of sialoadhesin and other, unpublished observations show that IL4 does not influence divalent cation-dependent erythroblast-binding activity. While IL4 is assuming the position of a dominant immunoregulatory molecule (23) , its role in influencing normal hemopoiesis is unclear. IL4 can act as a stimulant of mast cell growth, in that it will enhance IL-3-mediated effects in vitro (24) , and can also inhibit the capacity of bone marrow stromal layers to support the formation of granulocyte/macrophage colonies (25) . In these studies the nature ofthe stromal element involved was not confirmed, although the macrophages appeared to be implicated. IL4 can also reduce macrophage colony formation after addition to bone marrow progenitors stimulated with either GM-CSF or M-CSF (26) . It is therefore possible that IL4 may influence the development or growth of these cells by downregulating the expression of sialoadhesin receptors on stromal macrophages.
IL4 has other effects on macrophage function and/or receptor expression. For instance, treatment of murine macrophages with IL4 has been found to enhance antigenpresenting ability (27) , to increase expression of Ia antigen
